Exact Mass: 494.186

Exact Mass Matches: 494.186

Found 500 metabolites which its exact mass value is equals to given mass value 494.186, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Harpagoside

(E)-3-phenylprop-2-enoic acid [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] ester

C24H30O11 (494.1788)

Harpagoside is a terpene glycoside. Harpagoside is a natural product found in Verbascum lychnitis, Verbascum sinuatum, and other organisms with data available. See also: Harpagophytum procumbens root (part of); Harpagophytum zeyheri root (part of). Origin: Plant; SubCategory_DNP: Monoterpenoids, Iridoid monoterpenoids Harpagoside is isolated from Harpagophytum procumbens. Harpagoside has inhibitory effects on COX-1 and COX-2 activity and inhibits NO production[1]. Harpagoside is isolated from Harpagophytum procumbens. Harpagoside has inhibitory effects on COX-1 and COX-2 activity and inhibits NO production[1].

Amdro

hydramethylnon

C25H24F6N4 (494.1905)

D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4856; ORIGINAL_PRECURSOR_SCAN_NO 4854 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4845; ORIGINAL_PRECURSOR_SCAN_NO 4843 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4858; ORIGINAL_PRECURSOR_SCAN_NO 4856 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4880; ORIGINAL_PRECURSOR_SCAN_NO 4878 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9324; ORIGINAL_PRECURSOR_SCAN_NO 9322 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9337; ORIGINAL_PRECURSOR_SCAN_NO 9336 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9290; ORIGINAL_PRECURSOR_SCAN_NO 9289 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4940; ORIGINAL_PRECURSOR_SCAN_NO 4938 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4851; ORIGINAL_PRECURSOR_SCAN_NO 4847 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9266; ORIGINAL_PRECURSOR_SCAN_NO 9265 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9299; ORIGINAL_PRECURSOR_SCAN_NO 9298 CONFIDENCE standard compound; INTERNAL_ID 350; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9304; ORIGINAL_PRECURSOR_SCAN_NO 9303

3,6,9,12-Tetraazatetradecanedioic acid, 3,6,9,12-tetrakis(carboxymethyl)-

C18H30N4O12 (494.186)

D064449 - Sequestering Agents > D002614 - Chelating Agents

2-Hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide

1-(2-((3-Carbamoyl-4-hydroxy)phenoxy)ethylamino)-3-(4-(1-methyl-4-trifluoromethyl-2-imidazoylyl)phenoxy)-2-propanol methanesulfonate

C23H25F3N4O5 (494.1777)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

Harpagoside

4a,5-Dihydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1H,4ah,5H,6H,7H,7ah-cyclopenta[c]pyran-7-yl 3-phenylprop-2-enoic acid

C24H30O11 (494.1788)

14-Methoxytajixanthone-25-acetate

(-)-14-Methoxytajixanthone-25-acetate

6-O-Cinnamoyl harpagide

C24H30O11 (494.1788)

[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate

NCGC00384835-02![4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate

C24H30O11 (494.1788)

[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate

NCGC00384835-01![4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanoate

(S)-2-(3-(4-methoxyphenethoxy)-4-nitrobenzamido)-4-(4-methoxyphenyl)butanoic acid

C26H26N2O8 (494.1689)

4-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)benzyl 2,3-dihydroxy-2-(4-hydroxybenzyl)butanoate

C24H30O11 (494.1788)

EI-1511-3

(2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide

C27H30N2O7 (494.2053)

A polyene antibiotic isolated from the fermentation broth of Streptomyces sp.E-1625 that exhibits inhibitory activity towards the recombinant human interleukin-1beta converting enzyme (ICE). It also shows weak antibacterial activity against strains like Enterococcus faecium, Staphylococcus aureus and Bacillus subtilis.

WZ4002

N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide

C25H27ClN6O3 (494.1833)

D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

LEAD(II) 2-ETHYLHEXANOATE

C16H30O4Pb (494.191)

Z-Gly-Gly-Gly-Gly-Gly-Gly-OH

C20H26N6O9 (494.1761)

(4R,5S)-2-(4-(TERT-BUTYL)-2-ETHOXYPHENYL)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIMETHYL-4,5-DIHYDRO-1H-IMIDAZOLE

C29H32Cl2N2O (494.1892)

Toceranib phosphate

C22H28FN4O6P (494.173)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

d-pantothenic acid calcium salt hydrate

C18H34CaN2O11 (494.1788)

Arformoterol tartrate

C23H30N2O10 (494.19)

C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

(2-ethylhexanoato-O)(isooctanoato-O)lead

C16H30O4Pb (494.191)

Pigment Red 195

C32H22N4O2 (494.1743)

5-Trt-2-dI

C29H26N4O4 (494.1954)

Lead isooctanoate

C16H30O4Pb (494.191)

Spectinomycin hydrochloride

Spectinomycin dihydrochloride pentahydrate

C14H36Cl2N2O12 (494.1645)

C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(E)-N-hydroxy-C-(7-methylsulfanylheptyl)carbonimidoyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C19H34N4O7S2 (494.1869)

4-[3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6-dimethyl-9-oxoimidazo[1,2-a]purin-7-yl]-2-(methoxycarbonylamino)butanoic acid

C20H26N6O9 (494.1761)

Curvifloruside F

C24H30O11 (494.1788)

[(8R,9S,10R)-6-(2-fluorophenyl)sulfonyl-9-[4-(3-methylphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C28H31FN2O3S (494.2039)

15-O-propionylbruceolide

4-(3,4-Dimethoxybenzoyl)-5-(4-ethoxy-3-methoxyphenyl)-1-(5-methyl-1,2-oxazol-3-yl)pyrrolidine-2,3-dione

C26H26N2O8 (494.1689)

3,4,5-trihydroxy-6-[(14-hydroxy-3-methyl-1,7-dioxo-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecin-16-yl)oxy]oxane-2-carboxylic acid

C24H30O11 (494.1788)

(2S,3R,4S)-4-[(E)-2-[1-(carboxymethyl)pyridin-1-ium-3-yl]ethenyl]-3-ethenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid

C23H28NO11+ (494.1662)

[(4aS,5R,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate

C24H30O11 (494.1788)

spectinomycin hydrochloride hydrate

C14H36Cl2N2O12 (494.1645)

A hydrate that is the pentahydrate form of spectinomycin hydrochloride. An antibiotic that is active against gram-negative bacteria and used to treat gonorrhea.

2-Hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide

C23H25F3N4O5 (494.1777)

1-(β-carbolin-1-yl)-4-(4,8-dimethoxy-β-carbolin-1-yl)-2-methoxy-butan-1-one

C29H26N4O4 (494.1954)

{"Ingredient_id": "HBIN002385","Ingredient_name": "1-(beta-carbolin-1-yl)-4-(4,8-dimethoxy-beta-carbolin-1-yl)-2-methoxy-butan-1-one","Alias": "1-(\u03b2-carbolin-1-yl)-4-(4,8-dimethoxy-\u03b2-carbolin-1-yl)-2-methoxy-butan-1-one","Ingredient_formula": "C29H26N4O4","Ingredient_Smile": "COC1=CC=CC2=C1NC3=C2C(=CN=C3CCC(C(=O)C4=NC=CC5=C4NC6=CC=CC=C56)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30736;3160","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

4-O-methylpaeoniflorin

C24H30O11 (494.1788)

{"Ingredient_id": "HBIN010793","Ingredient_name": "4-O-methylpaeoniflorin","Alias": "NA","Ingredient_formula": "C24H30O11","Ingredient_Smile": "CC12CC3(C4CC1(C4(C(O2)O3)COC(=O)C5=CC=CC=C5)OC6C(C(C(C(O6)CO)O)O)O)OC","Ingredient_weight": "494.5 g/mol","OB_score": "25.70632536","CAS_id": "NA","SymMap_id": "SMIT08816","TCMID_id": "33122","TCMSP_id": "MOL007368","TCM_ID_id": "NA","PubChem_id": "46882921","DrugBank_id": "NA"}

4-o-methyl-paeoniflorin

C24H30O11 (494.1788)

{"Ingredient_id": "HBIN010794","Ingredient_name": "4-o-methyl-paeoniflorin","Alias": "NA","Ingredient_formula": "C24H30O11","Ingredient_Smile": "CC12CC3(C4CC1(C4(C(O2)O3)COC(=O)C5=CC=CC=C5)OC6C(C(C(C(O6)CO)O)O)O)OC","Ingredient_weight": "494.5 g/mol","OB_score": "25.70632536","CAS_id": "NA","SymMap_id": "SMIT08529","TCMID_id": "NA","TCMSP_id": "MOL007011","TCM_ID_id": "NA","PubChem_id": "46882921","DrugBank_id": "NA"}

ajugol; 6-o-(4-hydroxy-e-cinnamoyl)

C24H30O11 (494.1788)

{"Ingredient_id": "HBIN014996","Ingredient_name": "ajugol; 6-o-(4-hydroxy-e-cinnamoyl)","Alias": "NA","Ingredient_formula": "C24H30O11","Ingredient_Smile": "NA","Ingredient_weight": "494.49","OB_score": "NA","CAS_id": "124168-05-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7087","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl 3-phenylprop-2-enoate

C24H30O11 (494.1788)

(1s,19r,20s,22s,24r,25s,26s,27r)-19-ethenyl-25,26-dihydroxy-24-(hydroxymethyl)-21,23,28,29-tetraoxa-4,14-diazaheptacyclo[18.8.1.0²,¹⁸.0⁴,¹⁶.0⁷,¹⁵.0⁸,¹³.0²²,²⁷]nonacosa-2(18),7(15),8,10,12,16-hexaen-3-one

3-hydroxy-2,5,6-trimethylphenyl 4-(2,4-dihydroxy-3,6-dimethylbenzoyloxy)-2-hydroxy-3,5,6-trimethylbenzoate

C28H30O8 (494.1941)

(2e,4e)-n-[(1s,5s,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienimidic acid

(2e,4e)-n-[(1s,5s,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienimidic acid

C27H30N2O7 (494.2053)

3,24-dimethoxy-2-methyl-4-(methylimino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-16-ol

3,24-dimethoxy-2-methyl-4-(methylimino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-16-ol

C29H26N4O4 (494.1954)

6-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-4,7-dimethyl-hexahydrocyclopenta[b]pyran-3-one

C21H34O13 (494.1999)

(1s,2r,4r,5s,8s,10s)-12-[(acetyloxy)methyl]-5-hydroxy-4,8-dimethyl-7,13-dioxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl (2z)-4-(acetyloxy)-3-methylbut-2-enoate

C24H30O11 (494.1788)

(2s,3r,3as,4's,5'r,6s,7ar)-3,4'-dihydroxy-3-(hydroxymethyl)-5'-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-hexahydrospiro[1-benzofuran-2,2'-oxane]-6-carboxylic acid

C21H34O13 (494.1999)

n-{16-hydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl}-n-methylformamide

C29H26N4O4 (494.1954)